TARGETSCN TRANSRECTAL ULTRASOUND SYSTEM— 510(k) K041639

Name: FDA 510(k) clearance K041639
Creator: U.S. Food and Drug Administration
Published: 2004-09-02

Substantially Equivalent

Envisioneering, LLC

FDA 510(k) clearance K041639 for TARGETSCN TRANSRECTAL ULTRASOUND SYSTEM, Substantially Equivalent on 2004-09-02. Applicant: Envisioneering, LLC. Device class: 2.

Clearance details

Applicant: Envisioneering, LLC
Product code: Code IYO
Device class: Class 2
Regulation: 21 CFR 892.1560
Advisory panel: Radiology
Date received: 2004-06-17
Decision date: 2004-09-02
Decision: Substantially Equivalent
Clearance type: Traditional
Location: St. Louis, MO, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code IYO

view all

K253452 — Accuro 3S2026-07-24
K260190 — ARTHUR2026-06-18
K252237 — EdgeFlow UW202026-04-17
K254021 — Accuro XV2026-04-09
K253898 — QT Scanner 2000 Model A2026-03-04

More clearances from Envisioneering, LLC

view all

K073399 — TARGETSCAN BIOPSY KIT, TARGETSCAN BIOPSY NEEDLE GUIDE2007-12-21
K041638 — TARGETSCAN BIOPSY KIT2004-09-02
K041637 — TARGETSCAN TRANSRECTAL ULTRASOUND SYSTEM2004-09-01

Adverse events under product code IYO

product code IYO

Malfunction: 3,339
Total: 3,339

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.